Preoperative ATG bolus treatment increase CsA sensitivity of peripheral blood lymphocytes (PBLS) in renal transplant patients.
Abudher
M N
MN
Centre for Nephrology, Royal Free and University College Medical School, London, UK.
Moorhead
J F
JF
Fernando
O N
ON
Varghese
Z
Z
D000818:Animals; D000961:Antilymphocyte Serum / Q000008:administration & dosage / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D002460:Cell Line; D002478:Cells, Cultured; D016572:Cyclosporine / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D007275:Injections, Intravenous; D007376:Interleukin-2 / Q000096:biosynthesis; D016030:Kidney Transplantation / Q000276:immunology*; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology*; D051379:Mice; D011300:Preoperative Care; D013602:T-Lymphocytes, Cytotoxic
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D007376:Interleukin-2; D016572:Cyclosporine; D001379:Azathioprine